Medico Intercontinental Ltd
Incorporated in 1914, Medico Intercontinental
Ltd is engaged in trading of Pharmaceutical products[1]
- Market Cap ₹ 39.5 Cr.
- Current Price ₹ 39.5
- High / Low ₹ 63.6 / 34.2
- Stock P/E 15.7
- Book Value ₹ 37.6
- Dividend Yield 0.00 %
- ROCE 7.71 %
- ROE 5.40 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.05 times its book value
- Company is expected to give good quarter
Cons
- Company has a low return on equity of 7.77% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.02 | 0.27 | 0.23 | 2.03 | 0.00 | 9.95 | 46.93 | 41.02 | 39.25 | 48.88 | 44.04 | 61.89 | |
0.00 | 0.00 | 0.27 | 0.32 | 1.97 | 0.34 | 9.27 | 44.73 | 38.68 | 36.98 | 46.38 | 41.44 | 57.84 | |
Operating Profit | 0.00 | 0.02 | 0.00 | -0.09 | 0.06 | -0.34 | 0.68 | 2.20 | 2.34 | 2.27 | 2.50 | 2.60 | 4.05 |
OPM % | 100.00% | 0.00% | -39.13% | 2.96% | 6.83% | 4.69% | 5.70% | 5.78% | 5.11% | 5.90% | 6.54% | ||
0.00 | 0.00 | 0.00 | 0.00 | -0.05 | 0.39 | 0.36 | 0.02 | 0.16 | 0.18 | 0.34 | 0.42 | 0.41 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.66 | 0.78 | 0.52 | 0.37 | 0.22 | 0.53 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | 0.10 | 0.09 | 0.18 | 0.40 |
Profit before tax | 0.00 | 0.02 | 0.00 | -0.09 | 0.01 | 0.05 | 1.03 | 1.54 | 1.66 | 1.83 | 2.38 | 2.62 | 3.53 |
Tax % | 50.00% | -33.33% | 0.00% | 40.00% | 26.21% | 27.27% | 27.71% | 28.42% | 28.15% | 27.48% | |||
0.00 | 0.01 | 0.00 | -0.06 | 0.01 | 0.03 | 0.76 | 1.12 | 1.20 | 1.31 | 1.70 | 1.90 | 2.51 | |
EPS in Rs | 0.00 | 0.40 | 0.00 | -0.18 | 0.03 | 0.09 | 2.34 | 3.45 | 3.69 | 4.03 | 1.70 | 1.90 | 2.51 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% | 5.26% |
Compounded Sales Growth | |
---|---|
10 Years: | 116% |
5 Years: | 35% |
3 Years: | 2% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 69% |
5 Years: | 20% |
3 Years: | 17% |
TTM: | 24% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | -13% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 8% |
Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 3.25 | 10.00 | 10.00 | 10.00 |
Reserves | 0.02 | 0.04 | 0.04 | -0.02 | -0.01 | 0.02 | 0.78 | 1.90 | 3.09 | 4.40 | 24.30 | 26.10 | 27.58 |
0.02 | 0.02 | 0.02 | 0.23 | 0.02 | 0.02 | 0.09 | 8.56 | 4.81 | 6.21 | 2.27 | 0.96 | 7.82 | |
0.01 | 0.01 | 0.02 | 0.07 | 0.93 | 0.62 | 5.00 | 5.46 | 5.27 | 3.85 | 7.81 | 2.39 | 3.32 | |
Total Liabilities | 0.30 | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 48.72 |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.12 | 0.24 | 0.20 | 0.48 | 0.33 | 2.03 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 3.57 | 4.35 | 4.20 | 4.20 | 4.20 | 5.82 |
0.30 | 0.32 | 3.33 | 3.53 | 4.18 | 3.90 | 9.09 | 15.48 | 11.83 | 13.31 | 39.70 | 34.92 | 40.87 | |
Total Assets | 0.30 | 0.32 | 3.33 | 3.53 | 4.19 | 3.91 | 9.12 | 19.17 | 16.42 | 17.71 | 44.38 | 39.45 | 48.72 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | -2.96 | 0.12 | -0.04 | 0.02 | 0.95 | -6.55 | 5.44 | 1.10 | -11.95 | 5.73 | ||
0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.03 | -3.68 | -0.94 | -0.80 | -5.02 | -6.65 | ||
0.00 | 3.00 | 0.00 | 0.00 | 0.00 | 0.07 | 9.22 | -4.51 | 0.87 | 20.63 | -1.63 | ||
Net Cash Flow | 0.00 | 0.04 | 0.12 | -0.05 | 0.02 | 0.99 | -1.01 | -0.02 | 1.17 | 3.66 | -2.54 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 79.35 | 339.83 | 237.34 | 98.54 | 71.45 | 78.86 | 186.08 | 123.74 | ||
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 25.84 | 22.28 | 36.32 | 26.47 | 31.98 | 45.60 | ||
Days Payable | 200.54 | 45.26 | 51.21 | 39.76 | 64.82 | 19.26 | ||||||
Cash Conversion Cycle | 0.00 | 0.00 | 79.35 | 339.83 | 62.63 | 75.57 | 56.56 | 65.57 | 153.24 | 150.08 | ||
Working Capital Days | 4,927.50 | 4,380.00 | 5,125.87 | 345.22 | 78.50 | 76.45 | 57.13 | 66.86 | 157.11 | 143.30 | ||
ROCE % | 0.00% | 6.67% | 0.00% | -2.66% | 1.79% | 1.53% | 28.07% | 24.68% | 19.63% | 18.79% | 10.91% | 7.71% |
Documents
Announcements
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
8 Apr - Company not classified as Large Corporates for debt securities.
-
Announcement under Regulation 30 (LODR)-Meeting Updates
7 Apr - Investment of approx. ¥5.93 crores in Calborn Lifescience.
-
Board Meeting Outcome for In Compliances Of Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
7 Apr - Investment of approx. ¥5.93 crores in Calborn Lifescience.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Apr - Confirmation Certificate under SEBI Regulations for Q1 2025.
-
Closure of Trading Window
29 Mar - Closure of trading window for designated persons.
Business Overview:[1][2]
MIL (Formerly M/S. Intercontinental Leasing
& Finance Company Limited) was in the textile business. Currently, it trades pharmaceutical products related to Gastro, Uro, Nutrition, Cosmetology, Health Devices, Hospital,
etc.